Today is September 20, 2024. All times in Eastern Daylight Time.
El betaglucano Neu-REFIX recibe las designaciones de enfermedad pediátrica rara y medicamento huérfano de la FDA de EE. UU. para el tratamiento de la distrofia muscular de Duchenne
09/20/2024 - 01:23 PM
BUSINESS WIRE
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Allarity Therapeutics, Inc. (ALLR)
09/20/2024 - 01:13 PM
BUSINESS WIRE
CUPE Local 8911: Governance and Financial Review of E-Comm 9-1-1 System a Welcome Next Step
09/20/2024 - 01:10 PM
BUSINESS WIRE
Cognition Supplements Market Forecast Report 2024-2029, Featuring Profiles of Accelerated Intelligence, HVMN, Onnit Labs, Liquid Health, Quincy Bioscience, Natural Factors and Jarrow Formulas - ResearchAndMarkets.com
09/20/2024 - 01:09 PM
BUSINESS WIRE
Federman & Sherwood Investigates Oldenburg Group Incorporated and Visa Lighting for Data Breach
09/20/2024 - 12:53 PM
BUSINESS WIRE
AM Best Affirms Credit Ratings of StarStone Insurance Bermuda Limited and Its Subsidiary
09/20/2024 - 12:46 PM
BUSINESS WIRE
Vivendi: Canal+’s New Perimeter and Reporting Segments
09/20/2024 - 12:45 PM
BUSINESS WIRE
Vivendi : nouveau périmètre de Canal+ et segments d’activité
09/20/2024 - 12:45 PM
BUSINESS WIRE
Kommentar von AM Best: Das fehlende Element für eine deutsche Versicherungslösung gegen Naturkatastrophen heißt politischer Konsens
09/20/2024 - 12:41 PM
BUSINESS WIRE
Best's Commentary: Political Consensus the Missing Ingredient for Germany Natural Catastrophe Solution
09/20/2024 - 12:41 PM
BUSINESS WIRE
1
...
6
7
8
9
10
11
12
13
14
15
16
...
1489
« Previous
Next »